investors

We provide investors unique access to a diverse group of growth-ready assets in North America’s emerging cannabis market.

CannaRoyalty Corp. is a platform of holdings via royalty agreements, equity interests, secured convertible debt, and licensing agreements.

Significant opportunities exist to leverage our strengths and build new strategic partnerships, to meet the needs of patients and consumers, while creating shareholder value.

Stock Performance

Investors
CSE:CRZ : 1 Month Performance
Investors
CSE:CRZ : 1 Week Performance
beacon

Beacon Securities has initiated coverage of CannaRoyalty.

Please click here to go to their website where you may register for an account to access the report.

Featured News Releases

Upcoming Events

Canaccord Genuity Growth Conference

Date: Wednesday, August 9, 2017 | Time: 12:00pm EST
The webcast link will be available for 363 days following the conference.

Third Quarter 2017 Conference Call

Date: November 28, 2017 | Time: 8:30am EST
Participant Dial-in: 647-427-7450 or 1-888-231-8191
Replay Dial-in: 416-849-0833 ; 613-667-0035 or 1-855-859-2056
(Available for 2 weeks)
Reference Number: 97386572

CannaRoyalty Corp. – Financial Information

FY 2017

FY 2016

Annual

Bonanza Blue Corp. (Predecessor Entity) – Financial Information

FY 2016

FY 2015

Prior Year Financial Reports Can Be Found At SEDAR

FAQs

What is CannaRoyalty Corporation?

CannaRoyalty (CR) is a fully integrated, active investor and operator in the legal cannabis sector. Our focus is to build and support a diversified portfolio of growth-ready assets in high-value segments of the cannabis sector, including research, consumer brands, devices and intellectual property.

CannaRoyalty’s management team combines a hands-on understanding of the cannabis industry with seasoned financial know-how, assembling a platform of holdings via royalty agreements, equity interests, secured convertible debt and licensing agreements.

We invest in promising companies, brands, projects and assets in the United States, Canada and globally. As a strategic partner, our contribution includes capital, branding and functional expertise to advance commercialization and maximize return potential.

How can I invest in CannaRoyalty?

CannaRoyalty Corp. is trading on the Canadian Securities Exchange (CSE) under the stock symbol “CRZ” and in the US on the OTC under the stock symbol “CNNRF”. CannaRoyalty’s first day of public trading on the CSE was December 8, 2016. Live updates are available here. Please contact your broker if you wish to purchase shares in the company.

What companies and industry sectors does CannaRoyalty have interests/holdings in?

Currently, our platform of diversified holdings includes royalty agreements, equity interests, secured convertible debt, and licensing agreements in various businesses in Canada and the U.S.

This encompasses the medical and adult use cannabis sector and includes research, brands and devices, as well as other strategic investments.

To learn more about CR’s individual portfolio companies, please click here or on any of the categories below.

  • RESEARCH/IP : Developing intellectual property and patents in cutting-edge science, targeting health and wellness applications.

  • CR BRANDS : A premium positioned stable of consumer brands in medical, wellness, and animal health.

  • INFRASTRUCTURE : Industry infrastructure built to support and accelerate the commercialization of CannaRoyalty assets.

Does CR have Canadian holdings?

Yes. To date, our Canadian holdings and interests include Bodhi Research & Development Inc. and Resolve Digital Health.

Bodhi Research (Ontario) is a collaboration to explore the use of cannabis in the treatment of concussions and post-concussive syndrome with foremost expert in concussions, Dr. Neilank Jha (Neurosurgeon and Founder of Konkussion – the largest network of concussion clinics in North America). Research trials pending.

Resolve Digital Health (Toronto, Ontario) develops proprietary smart technology for the cannabis industry. Resolve’s Breeze Inhaler system is the world’s first smart inhaler with metered and monitored dosing technology, plus health program support and health team interconnectivity. Breeze Inhaler technology connects with the user’s smart phone via bluetooth to deliver rich information and integrated care.

CannaRoyalty has also acquired Electric Medialand (Ottawa, Ontario), an established full service digital marketing agency. Electric Medialand brings extensive expertise in cannabis sector marketing, branding and sales to support CannaRoyalty’s brands, drive commercialization and grow sales.

Who is the management team and board of CannaRoyalty?

Meet CannaRoyalty’s CEO Marc Lustig and read the CRHC management team and board member bios here.

What different types of investments has CannaRoyalty made to assemble its portfolio?

Our investment strategy involves royalty agreements, equity stakes, secured convertible debt and licensing agreements. An explanation of these investment categories, and relevant examples in relation to our business, is available here.

Can non-Canadian residents invest in CannaRoyalty?

Please consult with your broker to determine whether you are eligible to invest.

What U.S. states does CR have holdings in?

California, Florida, Washington (State), Oregon, Colorado and Arizona.

What is the growth potential of the U.S. legal cannabis market?

The US market is forecast to grow from $7.2 billion USD in 2016 to $22.8 billion by 2020 (ArcView Market Research). The 2026 Forecast is $50 billion (Cowen & Co.). In California alone (where CannaRoyalty has 8 holdings), the market is forecast to grow from its current $2.7 Billion to $6.6 billion by 2020 (ArcView Market Research).

How can I receive regular company updates?

You can subscribe to receive news and updates here.

STAY INFORMED
Sign up today. Receive the latest updates and discover the growth opportunities in the cannabis industry.